Tech Company Financing Transactions

Vera Therapeutics Funding Round

On 1/22/2021, Vera Therapeutics received $80 million in Series C investment from Abingworth, Alexandria Venture Investments and Fidelity Management & Research Company.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

170 Harbor Way 3rd Floor
San Francisco, CA 94080
USA

Phone

(650) 770-0077

Website

www.veratx.com

Email Address

[email protected]

Overview

Vera Therapeutics is a clinical-stage biotechnology company focused on developing treatments for immunological and inflammatory diseases. Vera's mission is to develop and commercialize transformative new therapies that improve patients' lives.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Marshall Fordyce

        

Chief Financial Officer

Jonathan Wolter

        

VP - Bus. Development

Joanne Curley

        

VP - Bus. Development

Lauren Frenz

        

VP - Operations

Thomas Doan

        

Browse more venture capital transactions:

Prev: 1/22/2021: Mivi Neuroscience venture capital transaction
Next: 1/22/2021: GlassesUSA.com venture capital transaction

Share this article

News on VC Transactions

Our team works diligently to report on all VC transactions involving tech companies. All VC database entries on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary